Clinique Laboratories, LLC Sustainability Profile
Clinique Laboratories, LLC, a prominent player in the skincare and cosmetics industry, is headquartered in the United States. Founded in 1968, Clinique has established itself as a pioneer in dermatological skincare, offering a range of products that cater to various skin types and concerns. The company is renowned for its allergy-tested and fragrance-free formulations, setting a high standard for safety and efficacy in beauty. With a diverse portfolio that includes skincare, makeup, and fragrance, Clinique's unique approach combines scientific research with innovative ingredients. The brand has achieved significant milestones, including being one of the first to introduce a dermatologist-developed skincare line. Clinique's commitment to quality and customer satisfaction has solidified its position as a leader in the global beauty market, making it a trusted choice for consumers seeking effective skincare solutions.
DitchCarbon Score
How does Clinique Laboratories, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Clinique Laboratories, LLC's score of 48 is higher than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Clinique Laboratories, LLC, headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of The Estée Lauder Companies Inc., which influences its climate commitments and emissions reporting. As part of its corporate family, Clinique Laboratories inherits climate initiatives and targets from The Estée Lauder Companies Inc. This includes participation in the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 initiative, all of which are aimed at reducing carbon emissions and promoting sustainability. However, specific reduction targets or achievements for Clinique Laboratories are not detailed in the available data. The Estée Lauder Companies Inc. has set ambitious climate goals, which may indirectly impact Clinique's operations and sustainability practices. As such, while Clinique Laboratories does not report its own emissions data, it aligns with the broader commitments of its parent company to address climate change and reduce carbon footprints across its operations.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2008 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 35,725,700 | 00,000,000 | 00,000,000 | - | - | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 68,649,100 | 00,000,000 | 00,000,000 | - | - | - | 00,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 2,060,947,660 | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Clinique Laboratories, LLC's Industry?
How Carbon Intensive is Clinique Laboratories, LLC's Location?
Clinique Laboratories, LLC's Scope 3 Categories Breakdown
Clinique Laboratories, LLC's Scope 3 emissions, which decreased by 8% last year and decreased by approximately 26% since 2008, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 48% of Scope 3 emissions.
Top Scope 3 Categories
Clinique Laboratories, LLC's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Clinique Laboratories, LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
